Improving research on Alzheimer's disease in Cote d'Ivoire
Official title: Building Research Infrastructure for Alzheimer's Disease and Related Dementias in Cote d'Ivoire
Funded at Johns Hopkins University · NIH-11035812 · Data updated 2026-11-12
This study is working to better understand Alzheimer's and related dementias in Cote d'Ivoire by teaming up with local organizations to gather important information and improve care for older adults, especially since their experiences can be quite different from those in wealthier countries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | April 15, 2025 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $517,593 |
| NIH project number | 1UG3AG090673-01 |
| Project ID | NIH-11035812 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 40 and older living in Cote d'Ivoire who may be affected by Alzheimer's disease or related dementias.
✕Less likely to help
Patients outside of Cote d'Ivoire or those under the age of 40 may not receive direct benefits from this research.
What this research studies
This research aims to enhance the understanding of Alzheimer's Disease and related dementias in Cote d'Ivoire by establishing a robust research infrastructure. It involves collaboration between Johns Hopkins University and local institutions to create data collection protocols and engage stakeholders in aging-related policies. The project focuses on the unique patterns of exposure and experiences of older adults in sub-Saharan Africa, which differ from those in higher-income countries. By building local capacity for ongoing research, the initiative seeks to address the growing burden of dementia in low- and middle-income countries.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of Alzheimer's disease in populations that are currently underrepresented in dementia research.
How similar studies have gone: While research on Alzheimer's disease has been extensive in high-income countries, this approach is novel as it focuses on low- and middle-income contexts, which have been less studied.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Anglewicz, Philip Anthony — Johns Hopkins University
- Study coordinator: Anglewicz, Philip Anthony
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.